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Abstract
Background: Recently, demand for and supply of short-form patient-reported outcome measures (PROMs) have
risen throughout the world healthcare. Our contribution to meeting that demand has been translating and culturally
adapting the Chronic Otitis Media Questionnaire-12 (COMQ-12) for adults into Serbian and enhancing its psychometric
base on the relatively large Serbian COM caseload. Chronic otitis media can seriously affect quality of life progressively
and in long-term, and it remains the major source of hearing problems in the developing world.
Methods: The translated questionnaire was given twice to 60 adult patients with chronic otitis media of three
types (inactive, active mucosal and active squamous disease) and to 60 healthy volunteers. Both patients and
volunteers also filled the generic Short-Form 36 questionnaire (SF-36). Conventional statistical procedures were
used in strategically driven development of scoring. Additionally, item responses were scaled by linear mapping
against the provisional total score. Generalizability, detailed factor interpretation and supportability of scores were
criteria, for the best compromise factor solution.
Results: Test-retest reliability was very high (0.924 to 0.989, depending on score). The a priori content dimensions
of the questionnaire were strongly supported by 3-factor exploratory and confirmatory factor analyses for content
validity, separating (i) ear symptoms from (ii) hearing problems, from (iii) daily activity restriction plus healthcare
uptake. The 3-factor structure was furthermore highly stable on replication. The very large effect sizes when
contrasting patients with healthy volunteers, and active with inactive disease established construct validity for the
total score. A strong association with disease activity and a moderate one with generic health-related quality of
life (HRQoL), the SF-36, supported construct validity for two of three factors extracted (ear symptoms, and impact
on daily activities plus healthcare uptake).
Conclusions: Given the minimal psychometric work to date on COMQ-12, this interim sample with 120 data
points adds materially to knowledge of its reliability, several forms of validity and the feasibility of profile sub-
scores to supplement total scores. The good psychometric properties shown for COMQ-12 justify both its routine
clinical use and acquisition of the necessarily larger sample for generality, score optimisation and the evaluation
of responsiveness.
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Background
Adult chronic otitis media (COM) is a major health prob-
lem and still the chief cause of preventable hearing disabil-
ity in the developing world [1]. It has been a relatively
small problem in the developed world through the anti-
biotic era, but may become a larger one again if that era
ends, as the growing resistance of bacteria threatens [2, 3].
The morbidity is definite and well established; due to an
erosion and destruction of tissues in the middle ear. The
considerable effect on quality of life (QoL) arises by two
main routes: persistent infection and mal-odorous dis-
charge from the ear, accompanied with discomfort, and
loss of hearing plus occasionally, balance function. De-
pending on the spread of disease, its degree of activity and
type, and on the appropriateness of surgical technique
used, rates of ‘surgical failure’ in disease management are
relatively high, especially in the active squamous form of
disease, reportedly from 16 to 29.4% [4]. These patients
particularly have high morbidity and resource demand,
many having repeated operations. Equally, success in re-
storing hearing is at best modest: in over 40% of patients,
hearing after surgery remains unchanged, and it can
sometimes even become worse [5]. Furthermore, if initial
hearing gains are accomplished, they can decline progres-
sively over time [6].
Given the variable treatment success of surgery and
hearing restoration, a comprehensive approach to the as-
sessment of the magnitude of impact of hearing loss and
accompanying symptoms in COM patients should be
established. Also, the contribution of hearing problems
and ear drainage considerations to treatment decisions
and successful management of the disease has yet to be
set out clearly. For monitoring quality of healthcare and
targeting or revising treatment strategies in COM, good
measurement of wider impacts as well as physical health
status and hearing are needed.
Measurement challenge
In recent years, even rare conditions have seen a flood
of short-form instruments (questionnaires) developed,
reported and applied for routine applications as patient-
reported outcome measures (PROMs) [7]. There have
been several such attempts to assess QoL in adult COM,
and to find validating relationships between this and
hearing levels (HL, audiograms) or other traditional clin-
ical measures (examination data, recurrence rates and
number of repeated office visits). Existing COM ques-
tionnaire measures seem not to well represent the per-
ceived hearing disability, unless using many hearing
items (so incompatible with short-form PROM status);
and they do not correlate well with overall quality of life
[5, 8]. Furthermore, measured hearing disability and
QoL seem to relate poorly in adult COM to the pre-
sumed bases in HL and other clinical data. Within the
developed world, these patients are mostly of lower so-
cioeconomic status and lower education, possibly limit-
ing sophisticated measurement, and the disease impact
might synergise with such factors; both these consider-
ations would demand many items to achieve measure-
ment precision, also large sample size. The social domain
of QoL in COM patients has never been assessed very
fully, despite these patients experiencing social isolation
due to both the hearing disability and the disease symp-
toms. A good general instrument should therefore reflect
this also.
The present article reports Phase 1 of a 2-phase psycho-
metric development project building on a review of the
existing Chronic Ear Survey (CES) [9] and Chronic Otitis
Media Outcome Test 15 (COMOT-15) [10]. The rationale
of Phillips et al. [11] in composing the successor, the
COMQ-12, was to use prior good items for hearing and
ear symptoms and to succinctly reflect wider impact; the
resulting COMQ-12 showed sufficient preliminary con-
struct validity to justify further development and evalu-
ation. The present work uses the Serbian caseload
(relatively high for a European country) to take the devel-
opment forward. Reference data now exist also on Flemish
(Dutch) and Russian versions of COMQ-12 with further
languages pending, but minimal further psychometric or
other evaluation has been reported [12, 13].
To help COMQ-12 take its justified next steps, we
have obtained a COMQ-12 translation and a substantial
reference sample for Serbian to undertake more detailed
psychometrics. The Phase 1 study reported here docu-
ments (a) the capabilities and potential of the instrument
more fully than has been done so far, addressing three
forms of validity (content, construct and metric), plus
reliability (test-re-test) and (b) the potential for profile
sub-scores. For such a very short instrument, the hetero-
geneity of disease facets involved needs to be bridged to
provide some total severity score; that aim is appropri-
ate, but achieving it with few items may threaten the via-
bility of sub-scores for profiling. This conflict of aims
reflects (and may be exacerbated by) an ambiguity over
the a priori affiliation of two COMQ-12 items that are
“wild cards” among COM symptoms: tinnitus (associ-
ated with hearing losses of both middle and inner ear
origin) and dizziness (an inner ear complication, but also
a central age-related symptom correlate). Both these
symptoms have large, though variable, effects on HRQoL
[14], justifying inclusion a priori in any ear condition. To
pursue aim (b) we address two related strategic meas-
urement issues, both practical, although the 1st also has
theoretical content: (i) is there a good factor structure
which can directly support content validity and probably
show construct validity? Then, if so, (ii) can the symp-
tom items originally included for totaling purposes also
contribute in a sufficiently structured way to support
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worthwhile sub-score profiling with COMQ-12? Alter-
natively, aim (ii) might only be achievable by adding fur-
ther items to fill revealed gaps; so, decision on (ii) is
urgent, to avoid possibly premature standardization pre-
venting achievement of that aim.
Methods
Translation
Linguistic and cultural adaptation of questionnaires
should follow well established principles and procedures.
After permission from the British originators, COMQ-
12 underwent forward translation into Serbian by a
medical translation agency using two independent trans-
lators (Serbs fluent in English). Small differences be-
tween the two translated versions were discussed and
reconciled by the agency editor (a native Serbian speaker
with formal education in Serbian language, also fluent in
English). This stage captured two instances of translation
error with missing content, solved by minor changes in
the reconciled version to ensure conceptual equivalence.
After a native English speaker had back-translated the
reconciled version into English, differences from the ori-
ginal English were discussed by one of the originators
with the 1st author for corrections and suggestions (only
one back translation error of lexical type found and cor-
rected). Piloting of the resulting preliminary Serbian ver-
sion with debriefing on 10 consecutive patients showed
that no modifications were needed for the final version
of the questionnaire (see Additional file 1).
Participants and data
Consecutive patients diagnosed with chronic otitis media
at the Clinic for Otorhinolaryngology and Maxillofacial
Surgery, in Clinical Centre of Serbia, Belgrade in the
period October 2014 to mid-January 2015, were in-
cluded. These (60) were supplemented by 60 healthy vol-
unteers. This Phase 1 study sample was heterogeneous,
comprising three roughly equal subgroups of patients
with different stages and activity of their disease: 20 pa-
tients had inactive chronic otitis media, 21 had active
mucosal disease and 19 had cholesteatoma. The ques-
tionnaire was self-reported, and all patients were asked
to fill one copy of COMQ-12 twice, at first visit, and
again 4 weeks later. There were no missing question-
naires or single items in this sample. They also filled in
the Serbian version of the generic health status measure
SF-36 [15] on the first occasion only. Supplementary pa-
tient data collected included age, gender, and pure-tone
audiograms (both ears) by air- and bone- conduction
hearing levels (contralaterally masked if the obtained
interaural difference for the frequency being tested was
greater than 20 dB, and always masked when determin-
ing bone conduction thresholds), plus in the clinical
group, the history of disease and oto-microscopic
findings. The normative reference volunteer group was a
comparable convenience sample without previous his-
tory of middle ear disease, composed from hospital staff
members of various grades. The larger sample for Phase
2 has patients only, including those from Phase 1, and
post-intervention longitudinal follow-up.
Statistical strategy and techniques
The main aim was to use the 120 data-points to make well
justified interim decisions about the scoring of the instru-
ment in basic respects (item contributions, supportable di-
mensions) and to specify issues remaining for an optimal
version, which might be addressed on a larger sample and
with longer-term follow-up. For the main standard statis-
tical procedures (eg chi-squared, t-tests, (M)ANOVA and
exploratory factor analysis) we used the satisfactory ver-
sions in SPSS version 22 and 23. The typical preliminary
approach ‘significance of any effect’ (gambling over exist-
ence of effects in small samples) is not scientifically appro-
priate, although we do make appropriate use of p-values
for determining inclusion of model terms. Given the need
for wider appreciation of the dual impact of COM, plus
the apparently modest and variable therapeutic gains from
surgery it is important to show and discuss effect sizes
(ESs) somewhat precisely [16]. The most widely used ES
measure, and best for appreciating differences in continu-
ous data on unfamiliar scales, is the standard deviation
(SD) effect size [17], for which near-normal distributions
are desirable. The normality of raw descriptives and of
model residuals was inspected visually and quantified by
skew and kurtosis indices (with standard-error-based tests),
supplemented by the Kolmogorov-Smirnov statistic. For
documenting content validity, exploratory principal com-
ponent and factor analyses (EFA) were performed with
Varimax orthogonal rotation, separately for baseline and
re-test occasions. After examining stability of factor struc-
ture, we combined the 2-visit data at the item level, to
maximise reliability of decision on the optimum basis for
extracting factor scores. Confirmatory factor analyses
(CFAs) to assist decisions about cross-loading were run via
structural equation modelling (SEM) [18] in the SPSS ad-
junct package AMOS. To appraise construct validity, these
CFAs were then extended to full SEMs by adding a priori
links from other relevant patient characteristics available;
in this CFA we also altered two of the 3 (necessarily low)
factor inter-correlations to regressions, allowing both hear-
ing and ear symptom factors to predict wider impact.
Results
Descriptive preliminaries and known-groups construct
validity
Table 1 details demographic and clinical characteristic of
patients and unaffected individuals (‘controls’), also base-
line severities in a limited range of variables at the first
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visit: air conduction thresholds for better- and worse-
hearing ears, plus the raw (ie unscaled and unweighted)
COMQ-12 total. The chief mean HL difference in the
baseline data, between the two active groups combined
and inactive, emerges as 20.687 on the affected ear, and
is almost identical at 20.156 on the worse. The SD effect
size for this affected ear mean HL difference against
pooled group absolute variability is very large at 1.56 SD
(t = 5.685; p < 0.001). There was no reliable difference
between study and control group in the mean age (t-test:
t = 0.446, df = 118; p = 0.657) nor in the gender balance
(Chi-squared = 0.137, df = 1; p = 0.711). Similarly, there
were no such differences between active and inactive
disease (respectively t-test: t = 0.667, df = 58, p = 0.507;
Chi-Sq = 0.543, df = 1; p = 0.461). Gender was therefore
not used further, and age failed to condition any of the
later comparisons of interest (but see later figure
footnote).
Average total raw score in the clinical group was 26.82
(SD 11.0) out of a maximum score of 60, ranging from 5
to 46, with an acceptably near-to-normal distribution
(Kolmogirov-Smirnov statistic 0.097, p~0.200; Shapiro-
Wilks statistic 0.967; p = 0.098). The three patient
groups have tractably slight skew and homogeneous SDs
around 10.00, so providing useful gradation in the clin-
ical population. The 60 healthy controls have extreme
positive skew (floor effect with few non-zero responses).
This entails that their very narrow SD cannot provide
the normal reference distribution nor even meaningfully
be incorporated into a pooled variance in the way com-
mon for computing the SD effect size. Using the square
root of the pooled variance estimate from the clinical
groups only, the health controls’ mean total raw score
was far (approximately two SDs) below even that of the
inactive group (Z = 6.997; p < 0.001) and about 3 SDs
below the two active groups combined (Z = 8.689;
p < 0.001). Thus, the questionnaire correctly locates the
patients in a distinctively pathological part of severity
space. As a more relevant demonstration, although the
two active groups do not differ from each other, they do
differ jointly from the inactive group. In the language of
‘significance’, this disease activity effect is reliable on the
present sample size (t = 3.67; df = 58; p = 0.001), but
more importantly has large enough effect size (1.005
SD) to conclude that known-groups construct validity
for the ear symptoms score is shown, and to proceed to
determine and use the factor structure.
Internal consistency and test re-test reliability for total
These checks were performed on unscaled items to jus-
tify work towards item scaling and weighting. Cronbach’s
alpha coefficient, the conventional index of consistency
or factorial purity, aggregates the inter-item correlations
to reflect a mixture of underlying reliability and validity.
For first visit this was 0.821, well above the conventional
threshold of acceptability (0.7) [19]. The Cronbach’s
alpha at Visit 2 retest was slightly better (0.84) possibly
due to increased participant familiarity with question-
naires. The between-visit intra-class correlation coeffi-
cient (ICC) value for the total was very high at 0.985
(95% confidence interval: 0.975 to 0.991). Further reli-
ability data (for scaled and factor scores) are given later.
Exploratory factor analysis and item scaling
We examined further inter-item relationships and dimen-
sion structure of the unscaled items with principal compo-
nent and factor analyses. All 12 questions showed sufficient
loadings on the first principal component (1st PC) to be
retained and scored in the total (minimally loading item for
the two visits, tinnitus: 0.429, 0.419, requiring further scru-
tiny in terms of profile contribution). Henceforth, we use
the saved weighted 1st PC values as giving a more opti-
mised precise metric for total score, but this is identical in
concept to the previously mentioned raw total and
Table 1 Basic 1st-visit descriptives of clinical groups and healthy individuals in Phase 1 Study
Data at 1st Visit Unaffected controls N = 60 Inactive COM N = 20 Active mucosal COM N = 21 Active squamous COM N = 19
Mean (SD), Skew Mean (SD), Skew Mean (SD), Skew Mean (SD), Skew
Age 43.52 (16.03), 0.153 44.20 (15.85), −0.180 45.47 (16.89), −0.173 36.47 (15.59), 0.891
Better ear average HL 24.81 (11.83), 0.885 32.14 (16.74), 1.352 33.09 (21.46), 1.393
Worse ear average HL 38.89 (11.76), 0.745 59.76 (17.26), 2.255 59.34 (16.32), 0.698
Raw total
COMQ-12
1.02 (1.88), 2.345 20.10 (8.40), 0.000 30.63 (9.99), −0.843 29.68 (11.75), −0.055
Disease duration %-ile split 50.0,50.0 38.1, 61.9 36.8, 63.2
Educational level %-ile split 55.0,45.0,0 50.0, 45.0, 5.0 42.9, 52.4, 4.8 26.3,68.4, 5.3
The percentages male and female in the COM groups totaling 60 were 43.3 & 56.7% and the percentage with left side affected (ie candidate ear for operation)
was 51.7%. The reported disease duration is expressed as the near-median split at 8 years, although it is recognised this figure may not be veridical. Educational
level is dichotomised at primary plus secondary, versus beyond secondary, then missing data. The apparently greater educational qualification level of the
squamous relative to other groups is not significant (Fisher Exact p, 2-tail 0.16). In each variable, skew standard errors are 0.512, 0.501, 0.524 for the three clinical
groups and 0.309 for controls. In the main analyses later using HL, the value is taken from the affected ear, ie the candidate for operation, as having more
disease-relevant variance. This is also in nearly all cases the worse ear. Though differing little here, age was extensively explored as a control covariate in analyses
subsequently reported, but it never improved model fit
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correlates with it highly, even at first visit (r = 0.997). The
1st PC also offers the most reliable basis for later optimising
the items’ contributions to the 1st PC total itself, by scaling
the intervals between their response levels in terms of units
on that 1st PC score.
For scaling these intervals, we heeded two possible
limitations: (a) in the scale-determining variable to be
predicted by item regressions, the presence of only about
4 high-loading items per factor make it prudent only to
use the 12-item principal component as scaling criterion
at this stage, for reliability’s sake; and (b) in the inde-
pendent variables (ie the response levels to be given co-
efficients) some categories have few instances (so wide
standard error) to reliably characterise extreme response
levels for their association with the generally extreme
total. We have therefore deferred to the larger Phase 2
the final optimised scaling of items by their various
levels’ contribution to respective factor scores on which
items load highly, rather than to 1st PC. Following the
method previously described [20], and with the unscaled
1st PC total for the 2nd visit’s data initially as the pre-
liminary dependent variable, we ran all 12 item-scaling
models using the univariate ANOVA version of the Gen-
eral Linear Model. This gave 12 sets of up to 6 decimal
scaled coefficient values with ‘missing’ and ‘not sure’ in-
cluded; these represent the mean differences in the pre-
liminary total values produced by those respondents
who gave the particular integer response level to the par-
ticular item. There followed several adaptive stages of
scaling, iterative in nature, to diminish any influence
from the starting point, although from previous large-
sample experience, one iteration generally suffices be-
cause of convergence. For the second round, the to-be-
predicted preliminary total was the scaled output from
the first round (visit 2), applied to the visits separately.
The high agreement obtained between the scale values
for the two visits’ data then justified averaging their
scaled values for each response level for items to total
and provide the dependent variable in the next round,
but items were again scaled for each visit separately. We
finally averaged scaling coefficients for Visit 1 and 2 data
to get reliable general scaled values from which we then
defined a principle component weighted total (Table 2
and the further comments on scaling in Additional file 2).
This convergence-based single scoring system was then im-
posed on the separate visit data for purposes of factor struc-
ture choice and definition of PC total score (Additional file
2 and Table 3); for reliability, further analyses proceeded on
the 2-visit averaged data with this average-derived scoring.
The value of scaling is illustrated by the present clear
falsification of the assumption that is made when just
using raw numerical ratings: that the intervals between
integer response levels are equal. One example, is
whether the supposed difference of 1.0 between ‘4’ and
‘5’ is truly equal in distinguishing overall severity to any
other such unit interval eg the 1.0 between ‘1’ and ‘2’.
The scaled values show that for three-quarters of all
items (exceptions 4, 6 and 12 being acceptable), this as-
sumption is seriously false. Thus, scaling can correct for
the evident ceiling effect in 9 of the 12 items, allowing
each item to do more work where it can. The note to
Table 2 and supplementary information in Additional
file 2 gives further examples.
We next compared parallel factor analyses on unscaled
versus scaled versions of the items to explore the appro-
priate factor solution. In the sequence of such strategic
decisions, this comparison was run in the first iteration
on the 2nd visit data, as participants became more famil-
iar with the questionnaire format, so give data slightly
less variable in a general sense. For unscaled item re-
sponse levels, 3 factors had explained 63.25% of the vari-
ance at visit 1; for scaled item response levels, this had
been no higher at visit 2 (62.90%), but the 3rd rotated
eigenvalue rose from 1.766 to 1.854. On the basis that
scaling may serve partly to aid the weaker factors, and
that reliability was also no worse with scaled data, this
favoured adopting scaled data for determining the best
factor solution via subsequent factor analyses. For
Table 2 Provisional scaled item response values
Response Level Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12
0 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
1 0.582 0.021 0.462 0.000 0.000 0.449 0.000 0.704 0.000 0.422 0.733 0.698
2 1.493 0.021 0.880 0.745 0.653 1.091 0.000 0.704 1.423 1.072 1.099 0.852
3 1.493 0.206 0.880 0.745 1.187 1.268 1.009 1.492 1.423 1.727 1.632 1.695
4 2.079 1.143 2.199 1.421 1.720 1.509 1.446 1.657 1.423 1.727 1.710 2.141
5 2.354 1.356 2.333 2.324 1.890 2.302 1.206 1.749 1.423 2.110 1.926 2.789
Short Item Key: 1 Q1 - Draining ear; Q2 - Smelly ear; Q3 - Hearing at home; Q4 - Hearing in noise; Q5 - Discomfort/pain; Q6 – Dizziness; Q7 – Tinnitus; Q8 -
Activity restriction; Q9 – Need to limit exposure to water; Q10 - GP visits; Q11 - Taking medicines; Q12 - Overall QoL impact of hearing problems
Entries are the adopted item response values for the 5 levels for each of the 12 questions when regressing them against a preliminary total score. Here that
dependent variable was the total 1st PC total (out of 5 X 12 = 60, unscaled, but scored continuously as integers), for the average of 1st two visits so in effect a
grain of 1/120 in the dependent variable. The exemplified independent variable category means estimated are the set from visit. The 12 scaling regressions
shown in Table 2 are done individually for the chosen dataset eg Visit 1, 2 combined), taking the responses of 0–5 as category labels for their means in the raw
total to be estimated from data by regression mapping, not as integer arithmetical values
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unscaled items, there had been four factors with eigen-
value > 1.00, but for scaled items there were only 3 at
this second visit. Because false-positive errors are pos-
sible in factor identification, “finding” more factors does
not necessarily make a solution better. The parsimony of
factor solution for various applications is also a goal; 3
factors are more supportable on 12 items than are 4.
The final model-choice approach to deciding between
a 3- and a 4-factor solution (on item-scaled and visit-
averaged data) is set out in detail in Additional file 2 and
Table 3. This was done based on the visit-averaged data
as justified in the first part of Additional file 2’s table.
There are four main reasons to not generally favour the
4-factor solution on the basis of these data: (a) the
amount of cross-loading is greater with 4 than with 3
factors, giving less neat factor interpretation, (b) the
minimal structural criterion of having 3 distinct high-
loading items is failed for one of the 4 factors; (c) there
is minimal gain in the performance indices in Table 3;
and (d) the last rotated eigenvalue is respectably high,
around 2.00 with three factors, but less so with four
(Table 3). The conventional narrow rule using all and
only the number of unrotated PC eigenvalues above 1.00
would also be failed here (the 4th was 0.910); however,
for eigenvalues between about 0.90 and 1.30, the four
considerations (a)-(d) above are also needed for a good
decision.
Thus, we proceed with three factors: ear problems,
hearing problems and combined impacts on daily activ-
ities and healthcare uptake. Multiple analysis of variance
showed no difference in any factor between the two ac-
tive forms (minimum pairwise p = 0.597), so this group
variable was collapsed to active/inactive.
Comprehensive view of construct validity including
confirmatory factor analysis and path model
The ‘significance’ of some expected correlation or differ-
ence does not well quantify validity. We therefore per-
formed confirmatory factor analysis (CFA) on the
combined visit data via structural equation modelling
[18] (SEM) using SPSS-AMOS. The CFA in the lower
half of Fig. 1 expresses the structure in a graphic and
comprehensible, but formally testable near-equivalent of
the 3-factor solution in EFA.
The latent variables in CFA are broadly but not pre-
cisely equivalent to EFA factors, as all low loadings are
forced to zero unless explicitly recognised by dual link-
age. In EFA the Varimax rotation uses the signs and
magnitudes of the lower-loading items to enforce zero
inter-factor correlation; in CFA contrastingly, at least k-1
inter-factor correlations have to be allowed and esti-
mated in a k-factor CFA. The regressions between latent
variables in SEM express these as potentially causal in-
fluences. The rows in the associated Table 4 summarise
the trade between goodness of fit and parsimony, as the
four strongest cross-loadings are reduced first to two,
then to just the one significant one (See Figure legend
for further detail). This was done in decreasing order of
magnitude of cross-loadings (as suggested by the 3-
factor EFA in Additional file 2) by backwards elimin-
ation. Also, deleted in the third CFA was the weak and
unnecessary factor link between generic impact and the
hearing factor. This left the comparator model for the
next step. We then turned the CFA model into a full
path (structural equation) model by adding (in the upper
half of the figure) three a priori construct-validity links
(a) disease activity influencing ear symptoms, (b) SF-36
psychological health, influencing responses about the
daily activities and healthcare uptake, and (c) measured
HL influencing reported hearing problems (weak,
p = 0.066, but note that p-values provided by AMOS
software are susceptible to which link is specified as ref-
erence, so it is more useful to apply a general notion of
marginality to SRWs below about 0.28 with this sample
size). A set of links such as a, b, and c is often called the
‘conceptual model’, with the factor analysis being called
the ‘measurement model’ and their mutual constraint
enhances validity.
Table 3 Percentage of variance explained by the factor solutions in Additional file 2
V1 3-FAC V2 3-FAC V12 average 3-FAC V12 average 4-FAC
Rotation SS Loadings Rotation SS Loadings Rotation SS Loadings Rotation SS Loadings
EV % variance Cum %var EV % variance Cum %var EV % variance Cum %var EV % variance Cum %var
2.818 23.484 23.484 3.152 26.267 26.267 3.008 25.065 25.065 2.626 21.884 21.884
2.466 20.550 44.033 2.436 20.297 46.563 2.520 20.998 46.064 2.167 18.060 39.943
2.282 19.021 63.054 2.055 17.126 63.689 2.182 18.186 64.249 2.083 17.362 57.305
1.744 14.531 71.836
EV = post-rotation eigenvalues; these are typically more evenly spread in their values than before rotation, Cum %var. = cumulative percentage of the variance
explained by factor scores, ie by adding the current absolute percent variance explained to the previous
The first two fields show straightforward 3-factor solutions on the data from each visit separately but with scale values based on Visit 1 and 2 averaged data com-
bined, making the scaling identical across all 4 fields although the data sources differ. In the last two fields, the item data themselves are averaged for the two
visits, so both the 3- and 4-factor solutions proceed on this same averaged Visit 1 & 2 data. The main text, supported by Additional file 2 b explains why visit-averaged
data and then the 3-factor solution are preferred
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Table 4 shows that the absolute fit of this path model
was less good at 0.136 than the conventional criterion
(RMSEA preferably ≤0.10 for ‘good’), and it was also
poorer than the fit seen for the pure CFAs (For details,
see Figure footnotes). This is because high general asso-
ciation (alpha) among comparable questionnaire items
that are visibly consistent is relatively easy to achieve,
despite here pushing the limit of a small number of
high-loading items per scorable factor (only 3 or 4),
making the grain of the data coarse. Also, as expected
from the literature, only one of the three construct valid-
ity links (observed disease activity➔ear problems) is
strong; in contrast, all but one of the factor-loading links
are strong, reflecting the consistency between
intrinsically similar questionnaire items. However, the
permutation index tells a complementary and favourable
story of structural uniqueness, whereby the model
grounding in non-questionnaire data can be judged
good, despite limitations in the data. As the number of
CFA links is reduced by eliminating the weaker ones,
there remain fewer (although still thousands of ) discov-
erable models of equivalent structure, and of these fewer
can have comparably good fit. On transitioning to the
path SEM, the number of possible models of similar
structure expands again, combinatorically; but most pos-
sibilities are not sensible and so most have relatively bad
fit. Thus, only a negligible number of equivalently- or
better-fitting models than the present SEM are found,
Fig. 1 Combined Confirmatory Factor Analysis and cascaded path regression model implemented in SEM. The graphical convention for expressing
structural equation models has observed variables as rectangles and underlying latent variables (essentially, factors) as ellipses with loading onto marker
variables (such as COMQ-12 question items here) as an outwards arrow. For additional simplicity and clarity here: a loading arrows are made thinner than
those for substantive regressions, b observable variables determining construct validity are italicised, but observable question items are not, and c the
error terms for the observable variables usually shown as a circle plus arrow into the for each are omitted. The juxtaposed numerals are standardised
regression weights (SRWs) a universal metric and one type of effect size, similar in concept to the factor loadings in Additional file 2, but on a different
scale. No ordinary item loading has standardised regression weight SRW less than 0.45, except the two for the cross-loading item 5 (discomfort/pain) at
0.41 and 0.26, so all items are doing useful work ‘marking’ the underlying factors (latent variables – ellipses). One marginal link had remained in the first
two CFA models, the inter-factor correlation between hearing symptoms and generic impact. However, in the third CFA, and in the full
SEM this is omitted as not necessary (CFA) and not improving fit (SEM). Major contrasts in link strength are seen within the construct
validity links. The large SRW for disease activity influence on ear symptoms score factor (0.65; p < <0.001) and the moderate one for SF-
36 on activities and uptake (−0.29; p = 0.013) contrast with the small and marginal one for hearing level on hearing factor score
(0.234; p = 0.066)
Table 4 Parsimony-adjusted goodness of fit for 4 SEM models of CFA and causal cascade pathways
Chi-sq df RMSEA AIC N better models found in 300 k permutations
CFA1 59.934 47 0.068 145.934 88
CFA2 64.037 49 0.072 146.037 24
CFA3 78.008 51 0.095 156.008 11
SEM 182.394 87 0.136 278.394 2
This table reflects the deletion of marginally loading items, and the addition of variables and links for one SEM (as in the Figure) to supplementing the CFA with
construct validity links from disease activity, HL, and SF-36. Significance of chi-squared is uninformative (as data always differ highly significantly from a model’s
predictions), but chi-squared values are the basis of calculating other indices of model fit. Lower df for CFA1 means fewer degrees of freedom in the residual error,
as more df are being ‘spent’ on links for the sake of goodness of fit (GoF), making a more complicated, but less parsimonious model (CFA1&2 compared to CFA3).
The RMSEA (root mean square error approximation) is the most generally used index [18] of GoF. The lowest (best) value here of RMSEA, 0.068, represents good
fit, verging on excellent (criterion RMSEA <0.05) and all loading links are very highly significant except the weaker cross-loadings (candidates for elimination). This
is for the first CFA with four items (Qs 5, 6, 7 and 9) cross-loading on a second factor, plus all three of the inter-factor correlation links realised. These links are next
reduced to two (CFA2), and then to one (CFA3, this also omitting the non-significant link between the hearing and activities/uptake factors). As determined by the
quality of the EFA solution, all these CFAs are highly parsimonious, with the parsimony-weighted Akaike Information Criterion undercutting the reference ‘satu-
rated’ value of 180. The SEM (last row) adding the three presumably causal links from disease activity, HL and the SF-36 mental well-being factor re-derived for this
sample comes close to absolute parsimony (Akaike AIC 278.394 only slightly higher than the target saturated value of 270) but with cross-loading of Question 5
on ear problems marginal at p = 0.085
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putting the SEM path model structurally in a good light.
Of 300,000 random permutations of the variables
around the model, only two were better than the path
model shown. Thus, the anchoring framework from the
CFA and SEM, goes far beyond the conventional mere
inter-correlation of within-score items (Cronbach’s
alpha); the directions of the 2 inter-factor links and the
2 significant construct validity links are causally plaus-
ible, so give the COMQ-12 a causal and theoretical as
well as empirical underpinning.
Reliability with principal component and factor scoring
Table 5 gives the now scaled test-re-test reliability indi-
ces for the weighted 1st principal component total and
for the now justified factor scores, as saved from the 3-
factor EFA solution. The scoring bridges any visit differ-
ence efficiently, by imposing the preferred combined-
visit derivation formula as single basis of scoring on the
separate-visit data. Whilst reliability in the sense of pre-
cision of measurement is inevitably limited with 3 or 4
items, reliability in the sense of test-re-test stability of
responses in these patients is evidently high.
Discussion
Reliability of total scores in COMQ-12
Promising basic properties of the item set were previously
documented on an English population [11], but this is the
first detailed psychometric analysis of COMQ-12 with
over 100 data points. Given the care over translation, and
the well-defined condition (so circumscribed patient
population, unlikely to be highly culture-dependent), it is
not surprising that good reliability and consistency are
shown for COMQ-12 total score in the Serbian version.
To justify assessing individuals, scales should be fairly
homogeneous (of which one index is the ability to extract
only one convincing PC). For application, Cronbach’s
alpha (essentially a homogeneity index) was traditionally
required to be above 0.8 (good), or even 0.9 (excellent)
[19]. However there are strong psychometric counterargu-
ments that very high alpha-values, especially if used as the
only development criterion, can breed superficial or overly
narrow measures [21]. They may also be unrealistic for
the total of a short-form outcome measure because in
work on quality of life the generic aim essentially guaran-
tees heterogeneity. Here, in order to reflect the three
domains necessary and provide some at least semi-generic
information on disease impact, the item set has also to be
heterogeneous, creating a conflict of aim where profile
sub-scoring is desired. The 3-factor solution requires
homogeneity within factors, but this makes the total item
set inhomogeneous across factors, so the overall alpha
values for total score of 0.825 and 0.847 (visits 1 & 2) can
be taken as assurance that the total refers to a sufficiently
coherent construct to be used in clinical settings. Similar
values for factor scores reflect the gain from within-factor
homogeneity, offsetting the loss of reliability with fewer
high-loading items. Of previously reported alpha values
for COMQ-12, one was slightly higher than ours, 0.889
for the English version [11]. For the Dutch version, the
ICC value was 0.859 [12], comparable with the present
one, suggesting that the English sample may have less het-
erogeneity and so less clear ability to support a factor
structure.
Item loading pattern and satisfactoriness of factor
solution
On scaling item response levels, the number of EFA
eigenvalues >1.0 dropped to 3, but giving an increase in
the total variance explained. This comparison and the sta-
bility seen between the Visit 1 and replicate Visit 2 factor
solutions suggested that reliability and generalizability
would be favoured by adopting scaled and averaged data
both for score definition and for addressing validity issues.
These three pre-requisite decisions taken, we justified
extracting 3 factors in rotated Varimax EFA; the similar
percentages of total variance explained (25% for daily
activities and healthcare uptake, 21% for hearing, and 18%
for ear symptoms) stem partly from the equal numbers of
highly loading items. This supportability of 3-factor profil-
ing combines with interpretative labels reflecting the
intended content domains, rooted in the traditional clin-
ical appreciation of the symptomatology, to give a satisfac-
tory solution.
Cross-loading is not a major problem in this sample;
unsurprisingly, CFA showed it in the 2-aspect ‘hearing
problems get you down’ (Q12: QoL in Table 2), although
the example remaining in the full grounded SEM, for
pain discomfort (Q5) is less explicable. Wild card items
were not an obstacle, with tinnitus affiliating mainly with
‘hearing function’ and dizziness with ‘ear problems’. The
Table 5 Test-re-test reliability of total and factor scores from EFA before and after scaling
Item scaling & scoring Raw Total,
Unscaled
1st PC Total,
Scaled
Scaled Fac1
Impacta
Scaled Fac2
Hearing
Scaled Fac3 Ear
symptoms
Scaled and scored as factors 0.989 0.983 0.968 0.924 0.944
Scaled, but scored as discrete item sets using high-
loading items only
– – 0.985 0.932 0.963
All reliabilities exceed the requirement for practical application, even those of the factors. Wider implications of reliability are addressed in the Discussion
a Daily activities and healthcare uptake; name abbreviated for formatting
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degree of cross-loading seen is acceptable, and in a very
short instrument mainly for PROM applications, where
the total score on small samples will probably be most
used, some cross-loading may even be helpful. This real-
ity, with the near equal division of the high loadings into
four or five items for each factor, discourages any deci-
sion to add other items that would also create a need to
re-standardise. COMQ-12 is shorter than many other
such instruments, yet offers both totalling and a sup-
portable set of sub-scores. The fundamental psychomet-
ric analyses in our work have been justified to achieve
some certainty about this conclusion and proceed next
to quantitative optimisation.
Forms of validity
The metric validity was slightly improved by item scal-
ing, suggested by its achieving a more satisfactory factor
solution. This still requires further investigation on a lar-
ger sample giving more instances of rare extreme re-
sponse levels, to quantify the role of such scaling in
optimising forms of validity including responsiveness of
the COMQ-12 to change. The present case/control
effect size was very high, and large effects were also pre-
viously reported [12, 22] as expected for a disease-
specific questionnaire, a pre-requisite for considering
other forms of validity. More importantly, since the
questionnaire aims to assess patients with the active
form of COM, the large effect size using the 1st PC total
score for disease forms active/inactive over 1.00 SD
showed high and relevant construct validity (in this ex-
ample it could also be called by the sub-type names of
‘discriminant’ or ‘known-groups’ validity).
The expected regression between HL and the hearing
score is only weak. Among possible explanations are in-
sufficient items to bridge the gap between an objective
measure of threshold sensitivity and a reported measure
having many determinants other than HL (as shown in
children [20]). Notably, the major effect on hearing in
COM is in the worse ear. However, in Table 1 the degree
of variation on the better ear is comparable, but it is only
correlated moderately with HL in the worse (r = 0.557).
Classically the major contribution to auditory disability and
to experienced problems is from the better ear [23], which
here may be minimally related to the COM, leading to
some dissociation between hearing measurements and item
responses about this condition of chief concern. The chief
issue here is practical: whether there is a justification to add
more hearing items to make a COMQ-13 or −14? The dis-
sociation suggests that the aim would be inappropriate. For
the semi-generic practical impact score (daily activities and
healthcare uptake questions), the correlation with the men-
tal scale of the truly generic SF-36 instrument (involving
mood and mental state) is satisfactory. In this light, the ra-
ther small effect size for disease activity on these partly
generic daily activities and service uptake, only 0.173 SD,
requires further probing. The strongest evidence for con-
struct validity comes from the SD effect sizes for disease ac-
tivity seen for hearing (0.795 SD) and ear symptoms (0.707
SD), both substantial, bordering on large, according to the
most widely used system of anchor terms [17].
Wider implications of factor structure for further
development
By scientific criteria of parsimony, stability and adequacy
on a mere 12 items, the 3-Factor solution was the most
satisfactory one. The 2-F solution showed poor interpret-
ability, but the issue remains of whether a 4-F solution
could be shown to be preferable in other circumstances.
Here, the 4-F was fairly similar to the 3-F; as frequently
occurs, the addition of one factor came from a split be-
tween two roughly equal subsets of items loading on one
existing factor – the division between health service up-
take and daily activities. A variety of circumstances could
favour that split, but the most obvious possibility, relevant
to international aggregation and international compari-
sons would be health culture and health systems. Where
these differed, for example by the interposition of a finan-
cial barrier and so some patient selection by economic in-
fluences, a driver for healthcare uptake separate from
impact on activities would be present, and so a factor split
could be anticipated. The Serbian healthcare system has
no major financial barrier of this nature.
Strengths and limitations
In ENT where the level of psychometric expertise is not
generally high, factor scores or other types of profile
sub-score have sometimes been offered without due cau-
tion over the trade-off between general reliability and
possible specific validity, the statistical strategy for ex-
traction, the interpretation and the empirical adequacy
of the scores used or offered [24]. As well as exemplify-
ing a rigorous approach to decisions leading to sub-
scores offered, our work has adhered to an overall statis-
tical strategy, respecting parsimony and a priori con-
straints, and explicitly justifying decisions, such as the
use of scaled values and number of factors extracted.
Respect for empirical adequacy is seen in the test-re-test
reliability and factor structure stability, and the report of
effect sizes not merely of superficial ‘significance’, eg
when claiming construct validity. We have addressed via
item-scaling the fundamental issue of equal interval scal-
ing, a prerequisite for using parametric statistics. We are
aware that wider quantification of scaling’s benefits (the
final recommendation of response-level scale values for
precision and generality) awaits further work on a larger
sample but have here justified that effort. Further docu-
mentation of three properties is still required; the wider
impact of COM, given only slight effect of disease
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activity upon impact (healthcare uptake and daily activ-
ity limitations); generalisability to a wider range of pa-
tients including internationally; and responsiveness to
change. Investment in such further work has also been
justified by the staged questions addressed and the an-
swers reached here.
Conclusions
1. In its Serbian translation, COMQ-12 has good reli-
ability, and the total score achieves conventional
consistency.
2. The factor structure of the item content is retrieved
with three factors as a basis for profile scoring,
currently labelled as: ear problems, hearing problems
and wider impact on daily activities plus healthcare
uptake.
3. This structure is remarkably stable over 1 month,
and scaled items retrieve it more satisfactorily than
do unscaled; thus, metrical validity (the unit basis of
scoring) has received attention in relation to a good
factor solution.
4. Theoretical (construct) validity has been enhanced
by an overall interpretable model relating the three
factors and three external associated measures,
embracing content and construct validities.
Diagnosed cases of adult COM show a very large
mean disease effect sizes of 2–3 SD relative to
healthy controls. Subscore profiling with three
factors is currently supportable for COMQ-12 in
large samples, because each factor has at least three
high-loading items. Although further items always
add reliability, they do not appear to be needed to
support this aim; thus standardizing the short-form
item set seems not to have been premature.
5. Because response levels are influenced by item
content, pending optimized item scaling on the
larger phase 2 sample (to best serve profile scoring)
the present scaled values offer a satisfactory way of
getting more structure out of COMQ-12 datasets
than alternative modes of scoring.
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